Merck KGaA (MKKGY)
OTCMKTS · Delayed Price · Currency is USD
26.04
0.00 (0.00%)
Nov 24, 2025, 4:00 PM EST
Merck KGaA Revenue
Merck KGaA had revenue of 5.32B EUR in the quarter ending September 30, 2025, with 0.99% growth. This brings the company's revenue in the last twelve months to 21.27B, up 1.47% year-over-year. In the year 2024, Merck KGaA had annual revenue of 21.16B with 0.78% growth.
Revenue (ttm)
21.27B EUR
Revenue Growth
+1.47%
P/S Ratio
2.26
Revenue / Employee
360.40K EUR
Employees
59,020
Market Cap
56.51B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 21.16B | 163.00M | 0.78% |
| Dec 31, 2023 | 20.99B | -1.24B | -5.57% |
| Dec 31, 2022 | 22.23B | 2.55B | 12.93% |
| Dec 31, 2021 | 19.69B | 2.15B | 12.28% |
| Dec 31, 2020 | 17.53B | 1.38B | 8.56% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Glass House Brands | 196.17M |
| Global Cord Blood | 196.10M |
| Elite Pharmaceuticals | 122.89M |
| Mid-Atlantic Home Health Network | 27.00M |
| Silence Therapeutics | 25.83M |
| Tian'an Technology Group | 2.12M |
Merck KGaA News
- 3 days ago - Equinix Hosts Merck KGaA's HPC at its Data Center in Germany - Nasdaq
- 4 days ago - Valo Health Partners with Merck KGaA in $3B AI Drug Discovery Deal - GuruFocus
- 4 days ago - Merck KGaA inks $3B deal to discover Parkinson’s drugs using AI - Seeking Alpha
- 4 days ago - Merck KGaA to draw on Valo's drug discovery AI in potential $3 billion deal - Reuters
- 4 days ago - Valo Health Announces Collaboration with Merck KGaA, Darmstadt, Germany to Discover and Develop Novel Treatments for Parkinson's Disease and Related Disorders - Business Wire
- 11 days ago - Merck KGaA (MKKGY) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 11 days ago - Merck KGaA 2025 Q3 - Results - Earnings Call Presentation - Seeking Alpha
- 11 days ago - Merck KGaA (MKGAF) Q3 2025 Earnings Call Highlights: Strong Organic Growth Amidst Market Challenges - GuruFocus